Novo valuation surpasses Tesla on experimental obesity drug data
Go back to Novo valuation surpasses Tesla on experimental obesity drug data| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1117.26 +10.18 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1107.08 | 52 Week High | $88.16 | |||
| Open | $1129.41 | 52 Week Low | $67.88 | |||
| Day High | $1135.14 | P/E | 258.63 | |||
| Day Low | $1100.98 | EPS | $4.32 | |||
| Volume | 2,907,958 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 47.41 -0.01 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.42 | 52 Week High | $59.00 | |||
| Open | $47.10 | 52 Week Low | $32.80 | |||
| Day High | $47.65 | P/E | N/A | |||
| Day Low | $47.02 | EPS | $0.00 | |||
| Volume | 15,077,719 | |||||
| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 37.87 +3.06 (8.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.81 | 52 Week High | $5.17 | |||
| Open | $35.63 | 52 Week Low | $0.94 | |||
| Day High | $38.08 | P/E | N/A | |||
| Day Low | $35.03 | EPS | $0.00 | |||
| Volume | 5,578,714 | |||||
